Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention.

Journal Article (Review;Journal Article)

Locoregional therapies can be offered to hepatocellular carcinoma patients as a bridge to transplant, to downstage disease burden for transplant eligibility, or for disease control to prolong survival. Systemic therapies also play a large role in HCC treatment, occasionally in conjunction with other methods. This manuscript reviews the various treatment options for HCC with a historically noncurative intent.

Full Text

Duke Authors

Cited Authors

  • Yacoub, JH; Mauro, D; Moon, A; He, AR; Bashir, MR; Hsu, CC; Fishbein, TM; Burke, LMB

Published Date

  • August 2021

Published In

Volume / Issue

  • 46 / 8

Start / End Page

  • 3540 - 3548

PubMed ID

  • 33864107

Electronic International Standard Serial Number (EISSN)

  • 2366-0058

International Standard Serial Number (ISSN)

  • 2366-004X

Digital Object Identifier (DOI)

  • 10.1007/s00261-021-03074-z


  • eng